Skip to main content
NewslettersWatchlist

Nexgenrx Inc(NXG-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.295
Day High0.295
Open:0.295
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
ACCESSWIRE
NexgenRx Announces Director Re-Appointment
AI-generated - The Globe and Mail
NexgenRx: Top 25 Undervalued Dividend Stocks on TSX-V (NXG)
ACCESSWIRE
NexgenRx Announces Share Issuances Under Consulting Agreement
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
ACCESSWIRE
NexgenRx Announces Declaration of Dividend
ACCESSWIRE
NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings
ACCESSWIRE
NexgenRx Announces Annual Meeting Results
AI-generated - The Globe and Mail
NexgenRx: Top 25 Undervalued Dividend Stocks on TSX-V (NXG)
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
ACCESSWIRE
NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
ACCESSWIRE
NexgenRX Announces Declaration of Dividend
ACCESSWIRE
NexgenRx Inc. Announces Q3 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
ACCESSWIRE
Nexgenrx Announces Q2 2023 Quarterly Results (With Continued Revenue Growth), Consulting Agreement and Option Grant
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
ACCESSWIRE
NexgenRx Announces Declaration of Dividend
The Globe and Mail
NexgenRx: Top 25 Undervalued Dividend Stocks on TSX-V (NXG)
The Globe and Mail
10 safe dividend stocks on the TSX Venture
ACCESSWIRE
NexgenRx Announces Q1 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA and Announces Election of New Director

Profile

NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.